Immune Checkpoint Inhibitor Nivolumab in People With Select Rare CNS Cancers (Q64150827)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immune Checkpoint Inhibitor Nivolumab in People With Select Rare CNS Cancers |
clinical trial |
Statements
Phase II Trial of the Immune Checkpoint Inhibitor Nivolumab in Patients With Select Rare CNS Cancers (English)
0 references
13 July 2017
0 references
31 December 2020
0 references
180
0 references
18 year
0 references
99 year
0 references